Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ketorolac × Other × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Plasma cell 1 Other 1 Lymphoid 1 Breast 1

Conditions

Obesity 1 Inflammation 1 Breast Neoplasms 1

Interventions

semaglutide 3 naldemedine 3 Specimen Handling 3 Metformin 3 Interviews as Topic 3 Tirzepatide 2 Tablets 2 Standard of Care 2 Paclitaxel 2 Observation 2 Methods 2 Exercise 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 Cisplatin 2 Carboplatin 2 Caloric Restriction 2 trametinib 1 tempol 1 sotorasib 1 selpercatinib 1 polyethylene glycol 3350 1 pembrolizumab 1 osimertinib 1 naloxegol 1 mirabegron 1 maltodextrin 1 lorlatinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡